Atracurium besylate 045 Epub 2012 Nov 23

Epub 2012 Nov 23

5 mg/day for 10 days effectively inhibits JAK2 V617F mutant-induced tumorigenesis and tumor cell invasion in nude mice

Roschzttardtz H

2-dimethyl-8-{[(4R)-5-methyl-3

TAE684 inhibits the proliferation of Ba/F3 NPM-ALK cells with an ICsub>50 of 3 nM

Atracurium besylate 045 Epub 2012 Nov 23Atracurium Besilate is a neuromuscular blocking drug or skeletal muscle relaxant in the category of non depolarizing neuromuscular blocking drugs, used adjunctively in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Atracurium is classified as an intermediate duration non depolarizing neuromuscular blocking agent. Product information CAS Number: 64228 81 5 Molecular